chemotherapy for brca-mutated prostate cancer
Published 5 years ago • 422 plays • Length 9:02Download video MP4
Download video MP3
Similar videos
-
6:32
metastatic prostate cancer: testing for brca mutations
-
1:09
dr. sweeney on chemotherapy in prostate cancer
-
12:07
parp inhibitors in brca1/2-mutated patients in prostate cancer
-
1:18
dr. gomella discusses role of brca1/2 in prostate cancer
-
1:07
understanding prostate cancer mutations is critical
-
1:01:28
emerging options for brca-mutated breast cancer treatment
-
2:29
dr. tagawa on brca2 in patients with prostate cancer receiving psma-targeted radionuclide therapy
-
1:27
dr. bryce on the fda approval of rucaparib in brca-mutant mcrpc
-
11:49
brca & parp inhibitors: targeted chemotherapy | #markscholzmd #alexscholz @pcri
-
1:32
dr. grivas on comparisons between atm and brca1/2 mutations in mcrpc
-
1:19
comparing abiraterone and docetaxel in prostate cancer treatment
-
0:49
how the breast cancer gene also impacts risk for prostate cancer
-
6:45
genetic testing and prostate cancer
-
1:50
brca2 gene implicated in rare but lethal prostate cancer
-
1:49
gyorgy petrovics on frequency of brca mutations in african american prostate cancer patients
-
2:45
therapy selection in brca-mutated ovarian cancer
-
1:56
dr. oh on targeted treatment in metastatic castration-resistant prostate cancer
-
6:18
value of olaparib in brca-mutated advanced ovarian cancer
-
0:54
potential of genetic testing beyond brca1/2 in ovarian cancer